Nassim Usman is the founder of Catalyst Biosciences. Catalyst Biosciences has raised $40M in total funding. Latest round: Series C.
Nassim Usman is the CEO of Catalyst Biosciences, a biopharmaceutical company focused on discovering and developing engineered proteases to treat various diseases. The company raised $40.4 million in a Series C financing round in December 2008, led by Essex Woodlands Health Ventures. Catalyst Biosciences is developing Alterase therapeutics for conditions such as hemophilia, age-related macular degeneration, oncology, and inflammation.
Full founder directory · Investor directory · Company funding database · Fundraising library